Resource Center
In 12 months, Nigeria's presidential initiative screened 1.5 million people and distributed over a million free reading glasses—with CHAI and partners contributing 800,000 pairs across 10 states.
Read more
This year's report checks in with our 2024-2028 strategy and our work to tackle persistent global health challenges even as the global health landscape has shifted.
Read more
CHAI has released the inaugural edition of its Triple Elimination Series, a set of market briefs examining market-shaping strategies to prevent vertical transmission of HIV, syphilis, and hepatitis B (commonly known as triple elimination). This first brief focuses on the introduction and scale-up of HIV/syphilis dual rapid diagnostic tests (RDTs), drawing on CHAI’s experience working...
Read more
The revolutionary HIV prevention tool, injectable lenacapavir, will be available at a cost of US$40 a year in 120 low- and middle-income countries starting in 2027, under a new partnership announced today between Dr. Reddy’s Laboratories and Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI.
Read more
As world leaders gather in New York this week for the UN High-Level Meeting on Non-Communicable Diseases and Mental Health, they’re confronting a stark reality: non-communicable diseases (NCDs) kill more people than any other cause globally yet receive only a fraction of health funding. But what if the solution isn’t just more money—what if it’s...
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
This white paper examines the opportunities and challenges for new manufacturers aiming to build globally competitive and commercially viable businesses in the low- and middle-income country vaccine markets.
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
Rwanda shows elimination is possible. But without urgent global action, treatment access could vanish—and lives with it.
Read more